Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Lubenow

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
European Journal of Immunology|June 5, 2003
Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cellsGunther Hartmann, Julia Battiany, Hendrik Poeck, et al.
Upsala Journal of Medical Sciences|October 10, 2013
Alternative diagnosis to heparin-induced thrombocytopenia in two critically ill patients despite a positive PF4/heparin-antibody testGregor Hron, Folke Knutson, Thomas Thiele, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 8, 2016
Impact of physical activity of individuals and creatine kinase on 99th percentiles of troponin I assaysAstrid Petersmann, Till Ittermann, Cornelia Frieß, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2004
Ex vivo analysis of human antigen-specific CD8+ T-cell responses: quality assessment of fluorescent HLA-A2 multimer and interferon-gamma ELISPOT assays for patient immune monitoringDaniel E Speiser, Mikaël J Pittet, Philippe Guillaume, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 11, 2016
Composition of growth factors and cytokines in lysates obtained from fresh versus stored pathogen-inactivated platelet unitsFelix Sellberg, Erik Berglund, Martin Ronaghi, et al.
Transfusion|September 23, 2020
Patterns of blood use in Sweden from 2008 to 2017: A nationwide cohort studyMarja-Kaisa Auvinen, Jingcheng Zhao, Ewa Lassén, et al.
Thrombosis Research|May 24, 2005
Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990sNorbert Lubenow, Theodore E Warkentin, Andreas Greinacher, et al.
Transfusion|June 22, 2007
Profiling of alterations in platelet proteins during storage of platelet concentratesThomas Thiele, Leif Steil, Simon Gebhard, et al.
Pharmacogenetics|May 2, 2003
Platelet receptor and clotting factor polymorphisms as genetic risk factors for thromboembolic complications in heparin-induced thrombocytopeniaLena E Carlsson, Norbert Lubenow, Carmen Blumentritt, et al.
Clinical Biochemistry|August 15, 2017
The 99th percentile and imprecision of point-of-care cardiac troponin I in comparison to central laboratory tests in a large reference populationAnne Greiser, Theresa Winter, Hala Mahfoud, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
European Journal of Immunology|June 5, 2003
Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cellsGunther Hartmann, Julia Battiany, Hendrik Poeck, et al.
Upsala Journal of Medical Sciences|October 10, 2013
Alternative diagnosis to heparin-induced thrombocytopenia in two critically ill patients despite a positive PF4/heparin-antibody testGregor Hron, Folke Knutson, Thomas Thiele, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 8, 2016
Impact of physical activity of individuals and creatine kinase on 99th percentiles of troponin I assaysAstrid Petersmann, Till Ittermann, Cornelia Frieß, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2004
Ex vivo analysis of human antigen-specific CD8+ T-cell responses: quality assessment of fluorescent HLA-A2 multimer and interferon-gamma ELISPOT assays for patient immune monitoringDaniel E Speiser, Mikaël J Pittet, Philippe Guillaume, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 11, 2016
Composition of growth factors and cytokines in lysates obtained from fresh versus stored pathogen-inactivated platelet unitsFelix Sellberg, Erik Berglund, Martin Ronaghi, et al.
Transfusion|September 23, 2020
Patterns of blood use in Sweden from 2008 to 2017: A nationwide cohort studyMarja-Kaisa Auvinen, Jingcheng Zhao, Ewa Lassén, et al.
Thrombosis Research|May 24, 2005
Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990sNorbert Lubenow, Theodore E Warkentin, Andreas Greinacher, et al.
Transfusion|June 22, 2007
Profiling of alterations in platelet proteins during storage of platelet concentratesThomas Thiele, Leif Steil, Simon Gebhard, et al.
Pharmacogenetics|May 2, 2003
Platelet receptor and clotting factor polymorphisms as genetic risk factors for thromboembolic complications in heparin-induced thrombocytopeniaLena E Carlsson, Norbert Lubenow, Carmen Blumentritt, et al.
Clinical Biochemistry|August 15, 2017
The 99th percentile and imprecision of point-of-care cardiac troponin I in comparison to central laboratory tests in a large reference populationAnne Greiser, Theresa Winter, Hala Mahfoud, et al.
Pageof 4